326607-90-3Relevant academic research and scientific papers
Synthesis, characterization and tyrosinase inhibitory properties of benzimidazole derivatives
Karatas, Mert Olgun,Alici, Bulent,Cetinkaya, Engin,Bilen, Cigdem,Gencer, Nahit,Arslan, Oktay
, p. 461 - 466 (2014)
1-Alkylbenzimidazole and 1,3-dialkyl benzimidazolium salts were synthesized and characterized by the data of IR, 1H NMR, 13C NMR spectra and elemental analyses. These compounds were investigated as tyrosinase inhibitors. Tyrosinase h
meta-Cyanobenzyl substituted benzimidazolium salts: Synthesis, characterization, crystal structure and carbonic anhydrase, α-glycosidase, butyrylcholinesterase, and acetylcholinesterase inhibitory properties
Türker, Ferhat,Barut Celepci, Duygu,Akta?, Ayd?n,Taslimi, Parham,G?k, Yetkin,Aygün, Muhittin,Gül?in, ?lhami
, (2018/05/30)
meta-Cyanobenzyl-substituted N-heterocyclic carbene (NHC) precursors were synthesized by the reaction of a series of N-(alkyl)benzimidazolium with 3-bromomethyl-benzonitrile. These benzimidazolium salts were characterized by using 1H NMR, 13C NMR, FTIR spectroscopy, and elemental analysis techniques. The molecular and crystal structures of 2f and 2g complexes were obtained by using the single-crystal X-ray diffraction method. The derivatives of these novel NHC precursors were effective inhibitors of α-glycosidase (AG), the cytosolic carbonic anhydrase I and II isoforms (hCA I and II), butyrylcholinesterase (BChE), and acetylcholinesterase (AChE) with Ki values in the range of 1.01–2.12 nM for AG, 189.56–402.44 nM for hCA I, 112.50–277.37 nM for hCA II, 95.45–352.58 nM for AChE, and 132.91–571.18 nM for BChE. In the last years, inhibition of the CA enzyme has been considered as a promising factor for pharmacologic intervention in a diversity of disturbances such as obesity, glaucoma, cancer, and epilepsy.
Synthesis and characterization of κ-2-bis-N-heterocyclic carbene rhodium(I) catalysts: Application in enantioselective arylboronic acid addition to cyclohex-2-enones
Jeletic, Matthew S.,Lowry, Roxy J.,Swails, Jason M.,Ghiviriga, Ion,Veige, Adam S.
supporting information; experimental part, p. 3127 - 3134 (2011/10/09)
This manuscript describes the synthesis and characterization of new derivatives of di-N-heterocyclic carbene (diNHC) ligands derived from trans-9,10-dihydro-9,10-ethanoanthracene-11,12-diylmethanediyl (DEAM) and trans-9,10-dihydro-9,10-ethanoanthracene-11
First selective CYP11B1 inhibitors for the treatment of cortisol-dependent diseases
Hille, Ulrike E.,Zimmer, Christina,Vock, Carsten A.,Hartmann, Rolf W.
supporting information; experimental part, p. 2 - 6 (2011/04/17)
Outgoing from an etomidate-based design concept, we succeeded in the development of a series of highly active and selective inhibitors of CYP11B1, the key enzyme of cortisol biosynthesis, as potential drugs for the treatment of Cushing's syndrome and rela
